Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SELADELPAR LYSINE vs SELEGILINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SELADELPAR LYSINE vs SELEGILINE: Safety Overview

Metric SELADELPAR LYSINE SELEGILINE
Total FAERS Reports 107 932
Deaths Reported 1 36
Death Rate 0.9% 3.9%
Hospitalizations 4 199
Average Patient Age 61.5 yrs 58.7 yrs
% Female Patients 94.3% 57.4%
FDA Approval Date Aug 14, 2024 Apr 1, 1997
Manufacturer Gilead Sciences, Inc Bausch Health US, LLC
Route ORAL ORAL
Marketing Status Prescription Discontinued